A slow reprogramming process reset age markers in blood cell precursors, giving researchers a model to study how cellular aging unfolds.
A cellular age reset that unfolds over weeks gives researchers something they often lack: a chance to watch rejuvenation happen. In a study published in Aging Cell, teams from the University Hospital of Bonn, the University of Bonn and RWTH Aachen University converted blood cell precursors from an 80-year-old person directly into neural stem cells. The resulting cells carried molecular age signatures associated with someone younger than 20.
The result represents more than 60 years of change on the cells’ molecular clocks. Its significance lies partly in the route the researchers used. Rather than first turning the cells into broadly capable pluripotent stem cells, they moved directly to a more specialized neural stem cell identity. The transition took place gradually, allowing the team to follow age-related changes across more than 100 days.
A direct route from blood precursors to neural stem cells
Cells in the body share essentially the same genetic instructions, but they use different parts of that information as they develop into specialized types. A blood cell and a neuron behave differently because distinct sets of genes are active. Reprogramming uses proteins called transcription factors to change which instructions a cell follows, redirecting its identity.
“Using this method, we have directly converted red blood cell precursors into neural stem cells,” said Prof. Dr. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn. Neural stem cells can produce cells found in the nervous system, making them a useful laboratory model for studying neural development and disease.
The Bonn group had previously reported that nerve cells produced through this approach could connect with existing neurons after transplantation into mouse brains. The new study asks a different question: what happens to cellular age during the conversion? The answer, according to the researchers, is that age-associated molecular patterns can shift substantially as the cells take on their new identity.
What the molecular clocks measure
To estimate age, the researchers examined epigenetic clocks. These measures rely on chemical marks on DNA that change in patterns associated with aging. The marks don’t change the DNA sequence; they influence how genetic instructions are used. Because some patterns vary predictably with age, researchers can use them to estimate a cell’s biological age at the molecular level.
After reprogramming, cells collected from the 80-year-old donor showed age signatures below 20 years. The study reports that the molecular age had fallen by roughly 60 years after about 50 days. Brüstle said the epigenetic reset also left the cells behaving like young cells.
That distinction matters. A younger reading on an age clock is a molecular measurement, and the research doesn’t show that a person’s body or brain has become decades younger. The reported findings concern cells reprogrammed in the laboratory. They offer a way to investigate how age-related marks change during cell conversion, while leaving any possible clinical application an open question.
Why the gradual process matters
Earlier studies had shown that reprogramming can reset cells’ biological age, but those experiments typically used a two-stage route. Researchers first transformed a mature cell into a pluripotent stem cell, which can develop into many cell types, then guided it toward a neural stem cell identity. In that sequence, rejuvenation happens relatively quickly, making intermediate changes harder to examine.
The Bonn team skipped the pluripotent stage. “In contrast, we converted blood cells directly into neural stem cells -- that is, without first passing through the pluripotent cell stage,” Brüstle said. “In our approach, rejuvenation occurred gradually and could be tracked for over 100 days.”
That extended window turns the process into an experimental model. Researchers can look for the point at which age markers begin to shift, identify changes that accompany the transition, and test whether particular factors or substances alter its pace. The study’s value, then, isn’t only the size of the age shift. It’s the opportunity to study the sequence of changes behind it.
Brüstle described the gradual reset as a way to investigate which factors and active substances might speed up or slow down rejuvenation. That could help researchers distinguish the changes linked to cell identity from those tied to age-associated molecular patterns. The study doesn’t establish which mechanisms are responsible for the reset or whether the same process can be applied safely or effectively in people.
Relevance to aging research and neuroscience
The team sees potential value for research into neurodegenerative disease, where age is a major risk factor. Studying neural stem cells that have undergone a measurable age reset could help scientists investigate how aging affects cells in the nervous system and how those changes relate to conditions such as Alzheimer’s disease.
Brüstle pointed to age as the most important risk factor for neurodegenerative diseases including Alzheimer’s. That makes the model relevant to questions about aging, but it doesn’t demonstrate a treatment for Alzheimer’s or a way to reverse aging in patients. Its immediate contribution is a laboratory system in which researchers can observe and probe a slow molecular transition.
The work involved scientists at the University Hospital of Bonn, the University of Bonn and RWTH Aachen University. Funding came from the EU’s Horizon 2020 program, the German Research Foundation (DFG), and the Federal Ministry of Research, Technology, and Space (BMFRT).
For aging research, the next useful step is to establish which processes drive the clock changes and how consistently they occur. The study gives researchers time to ask those questions during the conversion itself. That makes the gradual route a promising tool for understanding cellular aging, while the leap from a laboratory model to a medical application remains unproven.
Materials provided by University of Bonn. Note: Content may be edited for style and length.
Scientists Discover a Potential Early Warning Sign of Alzheimer’s in Adults As Young as 45
Late-Night Snacking Could Be Putting Your Liver at Risk
Scientists Say a Simple Blood Test Could Reveal Depression
40 Years of Superconductor Science Just Got Turned Upside Down by a Stunning Discovery
Stay informed with ScienceDaily's free email newsletter, updated daily and weekly. Or view our many newsfeeds in your RSS reader:
Keep up to date with the latest news from ScienceDaily via social networks:
Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Discussion
Sign in to join the discussion.